Results 151 to 160 of about 93,200 (346)

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard, Aaron Keal, James Hetherington, Sophie Barlow, David Wu, Melany Worbes‐Cerezo, Alexander Litvintchouk   +6 more
wiley   +1 more source

AB0949 Serum 25-hydroxyvitamin d status in patient with psoriatic arthritis [PDF]

, 2018
Shuhei Tsuji, Jun Hashi­moto, Takaaki Noguchi, Shosuke Akita, Kazuma Yachi, Shiro Ohshima, Yukihiko Saeki, Mari Higashiyama   +7 more
openalex   +1 more source

Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study [PDF]

, 2021
Yiyi Wang, Li Ding, Jihui Chen, Lingyan Zhang, Min Yang, Zhibin Liu, Liangliang Cheng, Tianjiao Lan, Gaojie Li, Yuanxia Gu, Yi Liu, Wei Li   +11 more
openalex   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Prevalence of circulating CD3CD4CD28 and CD3CD8CD28 cells in ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis

, 2011
Bernd Raffeiner, Christian Dejaco, Christina Duftner, Kullich Werner, Goldberger Christian, Vega, Sandra C, Keller Michael, Beatrix Grubeck‐Loebenstein, Michael Schirmer   +8 more
openalex   +1 more source

Serum and Fecal Calprotectin Levels Do Not Alter Significantly in Patients With Psoriasis Switching to Brodalumab After Loss of Effect From TNF‐α Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory skin disease often associated with systemic conditions like psoriatic arthritis and inflammatory bowel disease (IBD). Calprotectin, an inflammatory biomarker commonly used in IBD, has also been found elevated in psoriasis.
Admir Vižlin, Hans‐Peter Claesson, Ylva Andersch Björkman, Martin Gillstedt, Eva Klingberg, Emanuela Micu, Amra Osmančević   +6 more
wiley   +1 more source

Acrodermatitis continua of Hallopeau: clinical perspectives. [PDF]

, 2019
Acrodermatitis continua of Hallopeau (ACH) is a rare, sterile pustular eruption of one or more digits. The condition presents with tender pustules and underlying erythema on the tip of a digit, more frequently arising on a finger than a toe.
Beck, Kristen M, Bhutani, Tina, Liao, Wilson, Ly, Karen, Smith, Mary Patricia, Thibodeaux, Quinn   +5 more
core  

Methotrexate for psoriatic arthritis

, 2017
Tom D Wilsdon, Samuel Whittle, Tilenka Thynne, Arduino A. Mangoni   +3 more
openalex   +2 more sources

POS1068 DISCOVERY OF ARTHRITIS IN PSORIATIC PATIENTS FOR EARLY RHEUMATOLOGICAL REFERRAL (DAPPER): DEVELOPMENT OF A SCREENING TOOL FOR ACTIVE PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS [PDF]

, 2022
T. Van Hal, Michelle L M Mulder, Mark H. Wenink, J. M. P. A. van den Reek, E.M.G.J. de Jong   +4 more
openalex   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, EarlyView.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source